2021年对《内科医学年鉴》的研究显示,美国每年用于癌症筛查的支出为430亿美元,其中65%用于结肠癌筛查。 2021 study in Annals of Internal Medicine reveals that the US spends $43 billion annually on cancer screenings, with 65% allocated to colorectal cancer screenings.
根据"内科年鉴"上发表的一项研究, 美国每年在癌症初步查上花费超过400亿美元, 其中近三分之二用于结直肠癌查. The US spends over $40 billion annually on initial cancer screenings, with nearly two-thirds attributed to colorectal cancer screenings, according to a study published in the Annals of Internal Medicine. 该研究基于2021年的数据,发现癌症筛查费用占430亿美元,88.3%由私人保险支付,8.5%由医疗保险支付,3.2%由其他政府方案、无保险人员和医疗补助支付。 The research, based on 2021 data, found that cancer screening costs accounted for $43 billion, with 88.3% covered by private insurance, 8.5% by Medicare, and 3.2% by other government programs, uninsured persons, and Medicaid. 这项研究强调,必须解决癌症筛查费用和驱动因素问题,以改善获得建议的癌症筛查服务的机会,因为早期发现可以降低治疗费用,增加病人继续工作的机会。 The study underscores the importance of addressing cancer screening costs and drivers to improve access to recommended cancer screening services, as early detection can reduce treatment costs and increase patients' chances of continuing to work.